asundexian
bayer
['factor xi', 'congrat', 'asundexian', 'cardio']
a multicenter, phase 2, randomized, placebo-controlled, double-blind, trial of the oral factor xia inhibitor asundexian to prevent adverse cardiovascular outcomes following ami #esccongress congrats !!
Interventional cardiologist. Cardiology, Hospital Universitario de San Juan Alicante. Spain